Global (S)-(-)-4-Isopropyl-1,3-oxazolidinethione (CAS 104499-08-3) market size was valued at USD 28.4 million in 2025 and is projected to rise from USD 30.1 million in 2026 to USD 52.6 million by 2034, reflecting a steady expansion driven by the growing demand for enantiomerically pure intermediates across pharmaceutical and fine‑chemical sectors.

(S)-(-)-4-Isopropyl-1,3-oxazolidinethione is a chiral auxiliary that features an oxazolidinethione core with an isopropyl group at the 4‑position and a defined (S) configuration. Its high optical purity and robust Lewis‑acid character make it indispensable for stereoselective transformations such as Evans‑type aldol reactions, acylations, and beta‑amino acid synthesis. The reagent’s ability to deliver consistently high enantioselectivity underpins its value in the production of single‑enantiomer active pharmaceutical ingredients (APIs) and complex organic molecules.

The market is propelled by the pharmaceutical industry’s commitment to single‑enantiomer drugs, which offer superior therapeutic profiles. Additionally, the surge in asymmetric catalysis research and the expanding pipeline of stereospecific therapeutics reinforce sustained demand among academic institutions, contract research organizations, and specialty chemical manufacturers worldwide.

---

Key Market Drivers

Demand for chiral auxiliaries remains strong as new drug candidates increasingly require precise stereochemical control. The regulatory environment, particularly the stringent requirements of the FDA and EMA for chiral drug substances, reinforces the need for high‑purity reagents. In parallel, the evolution of asymmetric synthesis methodologies—especially Evans‑type protocols—continues to expand the role of oxazolidinethione derivatives in complex pharmaceutical intermediate manufacturing.

---

Top 10 Companies

1. MilliporeSigma (Sigma‑Aldrich)

Headquarters: United States / Germany
Key Offering: High‑purity chiral auxiliaries, custom synthesis services

MilliporeSigma leverages its extensive global distribution network and GMP‑compliant manufacturing to supply consistent enantiomeric excess (ee) and optical purity. The company’s focus on research‑grade products supports academic and industrial labs seeking reliable reagents for method development.

Sustainability & Growth Initiatives:

• Investment in green chemistry processes to reduce solvent use and waste.
• Expansion of custom synthesis capabilities to meet niche demand.
• Partnerships with academic institutions to accelerate new reaction development.

2. TCI Chemicals

Headquarters: Japan
Key Offering: Broad portfolio of chiral reagents, rapid turnaround service

TCI’s reputation for high‑quality chiral building blocks and its efficient logistics support laboratories worldwide. The company emphasizes strict quality control to maintain the reagent’s stereochemical integrity.

Sustainability & Growth Initiatives:

• Implementation of ISO 14001 environmental management systems.
• Development of low‑toxicity solvent alternatives.
• Expansion of online ordering platform for faster access.

3. Thermo Fisher Scientific (Alfa Aesar)

Headquarters: United States
Key Offering: Specialty chemical catalog, technical support

Thermo Fisher’s Alfa Aesar brand offers a comprehensive range of chiral auxiliaries, including (S)-(-)-4‑Isopropyl‑1,3‑oxazolidinethione. The company’s technical expertise facilitates troubleshooting and optimization for complex syntheses.

Sustainability & Growth Initiatives:

• Commitment to reducing carbon footprint across manufacturing facilities.
• Investment in renewable energy sources for production lines.
• Launch of a sustainability reporting portal for customers.

4. Combi-Blocks

Headquarters: United States
Key Offering: Custom chiral reagent synthesis, rapid prototyping

Combi-Blocks specializes in on‑demand synthesis of chiral compounds, offering flexible scale‑up options that cater to research groups needing tailored solutions.

Sustainability & Growth Initiatives:

• Adoption of modular synthesis platforms to reduce waste.
• Collaboration with universities to develop new chiral auxiliaries.
• Implementation of closed‑loop recycling for solvents.

5. AK Scientific (AKOS)

Headquarters: United States
Key Offering: Broad fine‑chemical catalog, technical assistance

AK Scientific offers a wide range of high‑purity reagents, with a focus on supporting both academic and industrial research. Their technical support team assists in optimizing reaction conditions.

Sustainability & Growth Initiatives:

• Integration of green chemistry principles into product development.
• Expansion of low‑cost chiral auxiliary options for budget‑constrained labs.
• Participation in industry consortia to promote sustainable practices.

6. Shanghai Macklin Biochemical

Headquarters: China
Key Offering: Local manufacturing, cost‑effective chiral reagents

Macklin Biochemical’s regional presence reduces lead times for Asian customers. The company focuses on delivering high‑quality reagents at competitive prices.

Sustainability & Growth Initiatives:

• Investment in energy‑efficient production lines.
• Collaboration with local universities to support method development.
• Development of scalable synthesis routes to meet growing demand.

7. Jiangsu Aikon Biopharmaceutical R&D

Headquarters: China
Key Offering: Research‑grade chiral auxiliaries, custom synthesis

Aikon Biopharma offers a portfolio of chiral reagents tailored to academic and industrial research needs, with a strong emphasis on maintaining optical purity.

Sustainability & Growth Initiatives:

• Implementation of waste‑minimization protocols in synthesis.
• Development of eco‑friendly solvent systems.
• Strategic partnerships with global research institutions.

8. Fluorochem

Headquarters: United Kingdom
Key Offering: Specialty chemical catalog, technical support

Fluorochem’s extensive catalog includes high‑purity chiral auxiliaries. The company supports customers with detailed product data sheets and reaction optimization guidance.

Sustainability & Growth Initiatives:

• Adoption of renewable feedstocks for reagent synthesis.
• Investment in advanced purification technologies.
• Collaboration with industry partners to promote sustainable chemistry.

9. Acros Organics (Thermo Fisher Scientific)

Headquarters: Belgium / United States
Key Offering: High‑purity chiral reagents, custom synthesis

Acros Organics provides a wide range of fine chemicals, including chiral auxiliaries, with a strong focus on quality and reliability for research applications.

Sustainability & Growth Initiatives:

• Implementation of green chemistry guidelines across production.
• Development of low‑energy synthesis routes.
• Support for academic research through grant programs.

10. ABCR GmbH

Headquarters: Germany
Key Offering: Fine‑chemical catalog, technical support

ABCR offers a curated selection of chiral reagents, emphasizing strict purity standards and rapid delivery for research labs.

Sustainability & Growth Initiatives:

• Use of renewable energy in manufacturing facilities.
• Investment in solvent‑recycling infrastructure.
• Partnerships with universities to foster method development.

---

(S)-(-)-4-Isopropyl-1,3-oxazolidinethione (CAS 104499-08-3) Market – View in Detailed Research Report

(S)-(-)-4-Isopropyl-1,3-oxazolidinethione (CAS 104499-08-3) Market – View in Detailed Research Report

---

Market Outlook to 2034

The trajectory of the (S)-(-)-4‑Isopropyl‑1,3‑oxazolidinethione market is anchored by the continued prioritization of single‑enantiomer drugs. Pharmaceutical companies are actively seeking efficient routes to produce enantiomerically pure intermediates, and the reagent’s proven performance in Evans‑type reactions positions it as a go‑to choice. As the pipeline of stereospecific therapeutics widens—particularly in oncology, infectious diseases, and CNS disorders—demand for high‑purity chiral auxiliaries is expected to grow steadily. Concurrently, the expansion of contract research and development organizations in Asia‑Pacific is likely to broaden the reagent’s application base, especially in large‑scale synthesis projects where scalability and cost efficiency are critical.

Emerging Trends Shaping the Future

1. Recyclable Chiral Auxiliaries – Researchers are exploring designs that allow the auxiliary to be recovered and reused, reducing material costs and waste. 2. Flow Chemistry Integration – Continuous‑flow processes are increasingly adopted for asymmetric reactions, offering improved heat management and scalability for oxazolidinethione‑mediated transformations. 3. Stereoselective Synthesis for Complex APIs – Advanced methodologies, such as photoredox‑catalyzed asymmetric reactions, are being merged with traditional Evans‑type chemistry to streamline the synthesis of challenging drug candidates. These trends collectively signal a shift toward more sustainable, efficient, and scalable production of chiral intermediates.